Question 1

What is the catalog number for IL-22 Blocking Peptide?

Accepted Answer

The catalog number for IL-22 Blocking Peptide is MBS8243326.

Question 2

What sizes are available for IL-22 Blocking Peptide?

Accepted Answer

IL-22 Blocking Peptide is available in the following size(s): 1 mg, 5 mg, 5x 5 mg.

Question 3

How many pack sizes does IL-22 Blocking Peptide come in?

Accepted Answer

IL-22 Blocking Peptide is available in 3 different pack sizes.

Question 4

Is IL-22 Blocking Peptide in stock?

Accepted Answer

IL-22 Blocking Peptide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

Question 6

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 7

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

IL-22 Blocking Peptide

Product Specifications

Gene Name

NCBI Gene ID

Reactivity

Storage Conditions

Other Gene Names

Short Name

Other Product Names

NCBI GI Number

NCBI Accession Number

Uniprot Accession Number

Available Sizes

Frequently Asked Questions

Explore Other Products

[5-Chloro-2- (2-methylpropyl) phenyl]-hydrazine

[5-Chloro-2- (2-methylpropyl) phenyl]-hydrazine

MLH3

Recombinant Pseudomonas putida NADH-quinone oxidoreductase subunit A (nuoA)

Recombinant Pseudomonas putida NADH-quinone oxidoreductase subunit A (nuoA)

SARS-CoV-2 (2019-nCoV) Nucleocapsid Mouse mAb Antibody